Skip to content

NAGE NAGE Depreciation

Depreciation at other companies

eXoZymes Inc. Common Stock logo
eXoZymes Inc. Common StockEXOZ
Abbott logo
AbbottABT
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
Olaplex Holdings, Inc. logo
Olaplex Holdings, Inc.OLPX

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's depreciation?
NAGE (NAGE) reported depreciation of $116K in Q1 2026.
How has NAGE's depreciation changed year-over-year?
NAGE's depreciation decreased by 26.6% year-over-year, from $158K to $116K.
What is the long-term trend for NAGE's depreciation?
Over 3 years (2021 to 2025), NAGE's depreciation has grown at a -11.7% compound annual growth rate (CAGR), from $890K to $612K.